Helwan University
Clinical trials sponsored by Helwan University, explained in plain language.
-
New drug combo shows promise in hodgkin lymphoma battle
Disease control CompletedThis study tested a new drug combination (brentuximab vedotin plus AVD) against the standard treatment (ABVD) for people with advanced Hodgkin lymphoma. Sixty patients took part to see which approach worked better and had fewer side effects. The goal was to improve disease contro…
Phase: NA • Sponsor: Helwan University • Aim: Disease control
Last updated May 26, 2026 11:35 UTC
-
Arm cuff trick may shield heart during attack
Disease control CompletedThis study looked at whether briefly restricting blood flow to the arm (using a blood pressure cuff) could reduce heart damage and improve recovery in patients having a heart attack treated with angioplasty. Only 2 people took part, so results are very limited. The approach aims …
Phase: NA • Sponsor: Helwan University • Aim: Disease control
Last updated May 26, 2026 11:35 UTC
-
New injection map could help diabetics avoid painful lumps and improve sugar control
Disease control CompletedThis study tested a new tool—a visual injection site map—to help people with diabetes rotate their insulin injection spots properly. 170 adults who had been on insulin for at least six months took part. Half received the map and instructions, while the other half got standard ver…
Phase: NA • Sponsor: Helwan University • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Heart drug showdown: which medicine better shields the right ventricle during valve surgery?
Disease control CompletedThis study looked at 52 adults having heart valve surgery who also had high blood pressure in their lungs. Doctors gave one group a drug called levosimendan and the other group dobutamine to see which one better helped the right side of the heart work after surgery. The team chec…
Sponsor: Helwan University • Aim: Disease control
Last updated May 06, 2026 16:15 UTC